Video
The Future of Telemedicine as the COVID-19 Pandemic Wanes
Mary Reed, DrPH, research scientist at Kaiser Permanente, discussed what changes would be necessary to continue providing quality virtual health care to patients with diabetes.
Pharmacy Times interviewed Mary Reed, DrPH, research scientist at Kaiser Permanente, on the subject of her 2021 ADA conference session, "Reimagining Diabetes Care in the Virtual World."
In this discussion, Reed focuses on what advances need to be made to provide patients with quality virtual health care even as the pandemic wanes. She urges practitioners not to abandon the telemedicine methods that were implemented due to COVID-19, and emphasized that patients who have experience with telemedicine are far more likely to want to use it again.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
